---
document_datetime: 2025-11-04 08:53:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vgenfli-epar-all-authorised-presentations_en.pdf
document_name: vgenfli-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7385122
conversion_datetime: 2025-12-28 00:38:09.996248
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging      | Content (concentration)   | Pack size                |
|------------------|-------------------|------------|------------------------|---------------------------|--------------------------|---------------------------|--------------------------|
| EU/1/25/1961/001 | Vgenfli           | 40 mg/ml   | Solution for injection | Intravitreal use          | pre-filled syringe (COP) | 0.165 ml                  | 1 pre-filled syringe     |
| EU/1/25/1961/002 | Vgenfli           | 40 mg/ml   | Solution for injection | Intravitreal use          | vial (glass)             | 0.278 ml                  | 1 vial + 1 filter needle |